Vincent van der Noort

Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer

Willemijn S.M.E. Theelen, Heike Peulen, Ferry Lalezari et al. · JAMA Oncology · 2019 · 935 citations · Full text

Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma

Joris L. Vos, Joris B.W. Elbers, Oscar Krijgsman et al. · Nature Communications · 2021 · 317 citations · Full text

Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold

David W. Vredevoogd, Thomas Kuilman, Maarten A. Ligtenberg et al. · Cell · 2019 · 252 citations · Full text

Immunotherapy Impact, Cancer Immunosurveillance, Immunology +5

Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma

Josine M.M.F. Quispel-Janssen, Vincent van der Noort, Jeltje F. de Vries et al. · Journal of Thoracic Oncology · 2018 · 244 citations · Full text

Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial

Maria Disselhorst, Josine M.M.F. Quispel-Janssen, Ferry Lalezari et al. · The Lancet Respiratory Medicine · 2019 · 243 citations

Oncology, Pleural Disease, Cancer Treatment +2